Wang, Hao http://orcid.org/0000-0002-8201-8006
Labus, Jennifer S.
Griffin, Fiona http://orcid.org/0000-0003-4275-9966
Gupta, Arpana http://orcid.org/0000-0002-1669-9624
Bhatt, Ravi R. http://orcid.org/0000-0003-2498-8888
Sauk, Jenny S.
Turkiewicz, Joanna
Bernstein, Charles N.
Kornelsen, Jennifer
Mayer, Emeran A. http://orcid.org/0000-0003-3923-3349
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK048351, K23106528)
China Scholarship Council (201906070121)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
National Science Foundation (2020290241)
Article History
Received: 19 May 2021
Revised: 4 December 2021
Accepted: 8 December 2021
First Online: 19 January 2022
Competing interests
: EAM is a scientific advisory board member of Danone, Axial Biotherapeutics, Viome, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences, APC Microbiome Ireland. CNB is on the advisory boards for Abbvie Canada, Amgen Canada, Bristol Myers Squibb Canada, Janssen Canada, Roche Canada, Sandoz Canada, Takeda Canada, and Pfizer Canada. CNB is also a consultant for Mylan Pharmaceuticals. CNB has received educational grants from Abbvie Canada, Janssen Canada, Takeda Canada, and Pfizer Canada. CNB has received research funding from Abbvie Canada. CNB is on the speaker’s bureau for Abbvie Canada, Janssen Canada, Takeda Canada, and Medtronic Canada. No other authors have anything to disclose.